Anixa Biosciences Inc Quarterly General and Administrative Expense in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Anixa Biosciences Inc quarterly/annual General and Administrative Expense history and growth rate from Q2 2019 to Q2 2024.
  • Anixa Biosciences Inc General and Administrative Expense for the quarter ending July 31, 2024 was $1.67M, a 5.07% decline year-over-year.
  • Anixa Biosciences Inc General and Administrative Expense for the twelve months ending July 31, 2024 was $7.18M, a 5.97% increase year-over-year.
  • Anixa Biosciences Inc annual General and Administrative Expense for 2023 was $6.29M, a 12.3% decline from 2022.
  • Anixa Biosciences Inc annual General and Administrative Expense for 2022 was $7.17M, a 1.4% increase from 2021.
  • Anixa Biosciences Inc annual General and Administrative Expense for 2021 was $7.07M, a 26.4% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.18M $1.67M -$89K -5.07% May 1, 2024 Jul 31, 2024 10-Q 2024-09-06
Q1 2024 $7.27M $1.82M +$210K +13% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-04
Q4 2023 $7.06M $2.26M +$772K +51.9% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-12
Q3 2023 $6.29M $1.44M -$488K -25.4% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-16
Q2 2023 $6.78M $1.76M +$404K +29.9% May 1, 2023 Jul 31, 2023 10-Q 2024-09-06
Q1 2023 $6.38M $1.61M -$243K -13.1% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-04
Q4 2022 $6.62M $1.49M -$554K -27.1% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-12
Q3 2022 $7.17M $1.92M +$20K +1.05% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-16
Q2 2022 $7.15M $1.35M -$869K -39.1% May 1, 2022 Jul 31, 2022 10-Q 2023-09-06
Q1 2022 $8.02M $1.85M +$439K +31% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $7.58M $2.04M +$509K +33.2% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 $7.07M $1.9M +$69.5K +3.79% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-04
Q2 2021 $7M $2.22M +$1.04M +87.9% May 1, 2021 Jul 31, 2021 10-Q 2022-09-09
Q1 2021 $5.96M $1.42M -$26.3K -1.83% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-10
Q4 2020 $5.99M $1.53M +$394K +34.6% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-11
Q3 2020 $5.6M $1.83M Aug 1, 2020 Oct 31, 2020 10-K 2022-01-04
Q2 2020 $1.18M +$125K +11.8% May 1, 2020 Jul 31, 2020 10-Q 2021-09-01
Q1 2020 $1.44M Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-10
Q4 2019 $1.14M Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q2 2019 $1.06M May 1, 2019 Jul 31, 2019 10-Q 2020-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.